Targeting Becn1 to inhibit autophagy significantly restores the levels of serine protease GZMB/granzyme B within target cells under hypoxic conditions and induces tumor regression in vivo by promoting NK cell-mediated tumor cell killing (109, 110). The gene discussed is BECN1; the disease is neoplasm.